115 related articles for article (PubMed ID: 11682199)
1. Gene transfer using human papillomavirus pseudovirions varies according to virus genotype and requires cell surface heparan sulfate.
Combita AL; Touzé A; Bousarghin L; Sizaret PY; Muñoz N; Coursaget P
FEMS Microbiol Lett; 2001 Oct; 204(1):183-8. PubMed ID: 11682199
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus type 31b infection of human keratinocytes does not require heparan sulfate.
Patterson NA; Smith JL; Ozbun MA
J Virol; 2005 Jun; 79(11):6838-47. PubMed ID: 15890923
[TBL] [Abstract][Full Text] [Related]
3. Positively charged sequences of human papillomavirus type 16 capsid proteins are sufficient to mediate gene transfer into target cells via the heparan sulfate receptor.
Bousarghin L; Touzé A; Combita-Rojas AL; Coursaget P
J Gen Virol; 2003 Jan; 84(Pt 1):157-164. PubMed ID: 12533712
[TBL] [Abstract][Full Text] [Related]
4. Generation and applications of HPV pseudovirions using vaccinia virus.
Sapp M; Selinka HC
Methods Mol Med; 2005; 119():463-82. PubMed ID: 16350418
[TBL] [Abstract][Full Text] [Related]
5. Detection of neutralizing antibodies against human papillomaviruses (HPV) by inhibition of gene transfer mediated by HPV pseudovirions.
Bousarghin L; Combita-Rojas AL; Touzé A; El Mehdaoui S; Sizaret PY; Bravo MM; Coursaget P
J Clin Microbiol; 2002 Mar; 40(3):926-32. PubMed ID: 11880418
[TBL] [Abstract][Full Text] [Related]
6. HPV pseudovirions as DNA delivery vehicles.
Ma B; Roden RB; Hung CF; Wu TC
Ther Deliv; 2011 Apr; 2(4):427-30. PubMed ID: 21709779
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus infection requires cell surface heparan sulfate.
Giroglou T; Florin L; Schäfer F; Streeck RE; Sapp M
J Virol; 2001 Feb; 75(3):1565-70. PubMed ID: 11152531
[TBL] [Abstract][Full Text] [Related]
8. Further evidence that papillomavirus capsids exist in two distinct conformations.
Selinka HC; Giroglou T; Nowak T; Christensen ND; Sapp M
J Virol; 2003 Dec; 77(24):12961-7. PubMed ID: 14645552
[TBL] [Abstract][Full Text] [Related]
9. Pseudovirions as specific tools for investigation of virus interactions with cells.
Sapp M; Selinka HC
Methods Mol Biol; 2005; 292():197-212. PubMed ID: 15507710
[TBL] [Abstract][Full Text] [Related]
10. Carboxy-fluorescein diacetate, succinimidyl ester labeled papillomavirus virus-like particles fluoresce after internalization and interact with heparan sulfate for binding and entry.
Drobni P; Mistry N; McMillan N; Evander M
Virology; 2003 May; 310(1):163-72. PubMed ID: 12788640
[TBL] [Abstract][Full Text] [Related]
11. Neutralization of human papillomavirus (HPV) pseudovirions: a novel and efficient approach to detect and characterize HPV neutralizing antibodies.
Yeager MD; Aste-Amezaga M; Brown DR; Martin MM; Shah MJ; Cook JC; Christensen ND; Ackerson C; Lowe RS; Smith JF; Keller P; Jansen KU
Virology; 2000 Dec; 278(2):570-7. PubMed ID: 11118379
[TBL] [Abstract][Full Text] [Related]
12. Assembly of human papillomavirus type 16 pseudovirions in Saccharomyces cerevisiae.
Rossi JL; Gissmann L; Jansen K; Müller M
Hum Gene Ther; 2000 May; 11(8):1165-76. PubMed ID: 10834618
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of transfer to secondary receptors by heparan sulfate-binding drug or antibody induces noninfectious uptake of human papillomavirus.
Selinka HC; Florin L; Patel HD; Freitag K; Schmidtke M; Makarov VA; Sapp M
J Virol; 2007 Oct; 81(20):10970-80. PubMed ID: 17686860
[TBL] [Abstract][Full Text] [Related]
14. Heparan sulfate-independent cell binding and infection with furin-precleaved papillomavirus capsids.
Day PM; Lowy DR; Schiller JT
J Virol; 2008 Dec; 82(24):12565-8. PubMed ID: 18829767
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus 16 virus-like particles use heparan sulfates to bind dendritic cells and colocalize with langerin in Langerhans cells.
Bousarghin L; Hubert P; Franzen E; Jacobs N; Boniver J; Delvenne P
J Gen Virol; 2005 May; 86(Pt 5):1297-1305. PubMed ID: 15831940
[TBL] [Abstract][Full Text] [Related]
16. Papillomavirus virus-like particles as vehicles for the delivery of epitopes or genes.
Xu YF; Zhang YQ; Xu XM; Song GX
Arch Virol; 2006 Nov; 151(11):2133-48. PubMed ID: 16791442
[TBL] [Abstract][Full Text] [Related]
17. HSV-1 virions engineered for specific binding to cell surface receptors.
Grandi P; Wang S; Schuback D; Krasnykh V; Spear M; Curiel DT; Manservigi R; Breakefield XO
Mol Ther; 2004 Mar; 9(3):419-27. PubMed ID: 15006609
[TBL] [Abstract][Full Text] [Related]
18. The use of virus-like particles for gene transfer.
Petry H; Goldmann C; Ast O; Lüke W
Curr Opin Mol Ther; 2003 Oct; 5(5):524-8. PubMed ID: 14601522
[TBL] [Abstract][Full Text] [Related]
19. Binding of human papilloma virus L1 virus-like particles to dendritic cells is mediated through heparan sulfates and induces immune activation.
de Witte L; Zoughlami Y; Aengeneyndt B; David G; van Kooyk Y; Gissmann L; Geijtenbeek TB
Immunobiology; 2007; 212(9-10):679-91. PubMed ID: 18086370
[TBL] [Abstract][Full Text] [Related]
20. Papillomavirus Infectious Pathways: A Comparison of Systems.
Biryukov J; Meyers C
Viruses; 2015 Aug; 7(8):4303-25. PubMed ID: 26247955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
